Apply for the MedTech Accelerator: Rapid Regulatory Support Fund

The programme will support SMEs that rely on external expertise to commercialise new products or re-register existing products in line with new regulatory requirements. SMEs working in MedTech can apply for funding for use with regulatory affairs providers to help with navigating regulatory pathways. 

There is a total of £4.2m Innovate UK investment, with projects to be awarded up to £30,000 per UK SME. SMEs can apply for reimbursement of activities conducted with an independent regulatory affairs consultant.

Organisations: CPI and the Office for Life Sciences
Project Start: Wednesday 9th October 2024 at 9am
Submission Deadline: Thursday 31st October 2024 at midday
Results Announced: by Friday 29th November 2024

On behalf of the UK Government’s Office for Life Sciences, CPI has created the MedTech Accelerator: Rapid Regulatory Support fund. It has been developed to help small and medium-sized business to navigate the complex and ever-changing MedTech regulatory landscape. 

The programme will support SMEs who rely on external expertise to commercialise new products, or re-register existing products in line with new regulatory requirements. 

Building on the success of the HealthTech Regulatory Innovation Programme (HealthTRIP) funded by Innovate UK in 2022, we aim to again support hundreds of UK SMEs to overcome regulatory hurdles. The HealthTRIP project awarded funding to 277 companies, find out more here:

Applications open on Wednesday 9th October 2024, at 9am and close on Thursday 31st October 2024, at midday.

We will review applications regularly, and if we receive 300 before the deadline, we will close applications early. Companies are, therefore, encouraged to apply as soon as they can.

Funding is aimed at UK SMEs developing or offering medical device (including Software as a Medical Device) and diagnostics (including IVD) products or services. Although pharmaceutical products are not considered eligible under this programme, combination medical products such as drug delivery devices would be considered eligible. 

Why you should apply

The regulatory landscape for MedTech is constantly changing, including a divergence between the UK and EU systems. This is leading to some UK companies finding their products no longer meet the regulatory requirements to be sold within the EU. SMEs seeking to commercialise their products often suffer from a lack of internal expertise in the regulatory process, leading to challenges in developing a compliant product and a reliance on external support. This presents a financial and knowledge barrier to many small businesses. The MedTech Accelerator: Rapid Regulatory Support fund aims to help SMEs overcome this barrier.